Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Lehman who wrote (979)	7/5/1998 10:25:00 PM
From: Edward W. Richmond	Read Replies (1) \| Respond to of 1501

Harold, I will attend the AGM if it falls on a convenient day and time. If it is called for 2:00 pm, the traffic will discourage small investors from attending. Also, watch for the downward repricing of options. I speak and vote against this ever time I am faced with it. Keep pushing for information. Regards, Ed

To: Harold Lehman who wrote (979)	7/6/1998 12:53:00 AM
From: Charles Salski	Read Replies (1) \| Respond to of 1501

Harold and All, I was doing some DD and came across this bit of information on Inflazyme Pharmaceuticals Ltd. From Canada Stockwatch Participants involved with Inflazyme Pharmaceuticals Ltd SUPERGEN bought an asset from Co 9707 was disclosed as a shareholder of Co 9711 (What asset ? I don't remember seeing a PR from IZP) BIOTECH INV bought a private placement in Co 9702 was disclosed as a shareholder of Co 9702 ( Anybody know who they are???) From the May 6 1998 Press Release Inflazyme Pharmaceuticals Ltd. Appoints New President << The Board believes that Mr. McBeath's international experience and contacts will be invaluable as Inflazyme enters its next stage of development in seeking strategic alliances with multinational pharmaceutical partners. >> << The Board of Inflazyme welcomes Mr. McBeath's appointment and have confidence that, under his leadership, the company will be able to accelerate the development and commercialization of its technologies. Mr. McBeath is to be appointed to the Inflazyme board of directors, replacing Dr. Hassan Salari who recently stepped down. >> Wednesday April 1,1998 Press Release Inflazyme Pharmaceuticals Appoints Dr. Hassan Sslari As Head Of Discovery Friday June 26,1998 Press Release Inflazyme also announces that Dr. Hassan Salari, formerly Head of Discovery,is no longer employed with the Company. (Short honeymoon !!) With the departure of Dr. Hassan Salari and these recent appointments as directors. Layne Donald S became a director of Co 9711 Liggett Michael was disclosed as an officer of Co 9704 became a director of Co 9712 McConnell William became a director of Co 9801 Any comments as to what direction this company maybe heading for ? Regards, Charles